Genetic and environmental effects in paroxysmal nocturnal hemoglobinuria: this little PIG-A goes “Why? Why? Why?”
Open Access
- 1 September 2000
- journal article
- editorial
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 106 (5), 637-641
- https://doi.org/10.1172/jci11002
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Impaired growth and elevated Fas receptor expression in PIGA+ stem cells in primary paroxysmal nocturnal hemoglobinuriaJournal of Clinical Investigation, 2000
- HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokineNature Medicine, 2000
- Immunosuppressive treatment of aplastic anemia with antithymocyte globulin and cyclosporineSeminars in Hematology, 2000
- Cytotoxicity against lymphoblastoid cells mediated by a T-cell clone from an aplastic anaemia patient: role of CD59 on target cellsBritish Journal of Haematology, 1999
- Paroxysmal Nocturnal Hemoglobinuria Cells in Patients with Bone Marrow Failure SyndromesAnnals of Internal Medicine, 1999
- High Incidence of Transiently Appearing Complement-Sensitive Bone Marrow Precursor Cells in Patients with Severe Aplastic Anemia - A Possible Role of High Endogenous IL-2 in Their SuppressionActa Haematologica, 1999
- The Pathophysiology of Acquired Aplastic AnemiaNew England Journal of Medicine, 1997
- Somatic Mutations in Paroxysmal Nocturnal Hemoglobinuria: A Blessing in Disguise?Cell, 1997
- A knock-out model of paroxysmal nocturnal hemoglobinuria: Pig-a(-) hematopoiesis is reconstituted following intercellular transfer of GPI-anchored proteins.Proceedings of the National Academy of Sciences, 1996
- Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuriaCell, 1993